International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-2 doi: 10.5281/zenodo.7747910
Original Article
A Clinical Study of Incidence and Determinants of Ectopic Pregnancy in a Tertiary Centre
 ,
 ,
Published
March 18, 2023
Abstract
Ectopic pregnancy is leading cause of maternal morbidity and mortality in first trimester. It accounts for 2% of all pregnancies. Aims and objectives: To find out the incidence of ectopic pregnancy in our hospital and to determine the risk factors, clinical presentation, management and outcome of ectopic pregnancy. Methods: A Hospital based Retrospective clinical study carried out in Department of Obstetrics and Gynaecology of Sapthagiri Institute of Medical Sciences and Research Centre, Bengaluru for four years from August 2019 to August 2022. Results: The incidence of ectopic pregnancy was 2.8%, of which 93.93% were ruptured, 6.06% unruptured and 4.54% heterotopic pregnancies. Maximum patients (65%) were among age group of 21 to 30 years and were multigravida, 45.4% presented between 7-8+6 weeks of gestation. The common risk factor was previous abortion with Dilatation and curettage. Surgical management with salpingectomy was done in majority of cases(86.3%). 91% of ectopic pregnancy was in fallopian tube, 2 in ovaries and 1 in rudimentary horn of bicornuate uterus. The commonest site was ampulla (45.4%). Outcome was studied by need of blood transfusion in 39.3%, ICU admission in 15.15%. No maternal mortality encountered in this study. Conclusion: Since the incidence of ectopic pregnancy is on raising trend, high index of suspicion, early diagnosis and management are required to reduce maternal morbidity and mortality and for conservation of future reproductive capacity.
Recommended Articles
Loading Image...
Volume-4, Issue-2
Citations
1139 Views
484 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved